ProfOsama Soliman
Professor
Anatomy and Regenerative Medicine
IMPACT AND ENGAGEMENT OVERVIEW
Prof. Soliman’s work has significantly shaped clinical practice, digital innovation, and patient outcomes across cardiovascular medicine:
Digital Health Impact: Architect of the first Cardiovascular Digital Twin Framework in Ireland, now expanded across multiple EU partnerships.
Clinical Impact: Developed the EUROMACS RHF Risk Score used internationally for managing LVAD patients and led the EuroEchovAD, EuroLEVOVAD, EEVAD trial, one of Europe’s largest prospective HeartMate 3 cohorts.
Industry Impact: He has partnered with Abbott, Medtronic, Boston Scientific, and others in over 20 major international clinical trials, leading Imaging Core Lab analyses and trial design.
Academic Impact: Over 400 peer-reviewed publications in top journals including New England Journal of Medicine, The Lancet, European Heart Journal, Circulation, JACC, H-index: 57, and senior authorship on ESC/EACVI consensus documents.
Societal Impact: Through leadership of the UCARE and INCEPTION studies, he has elevated cardio-oncology care in Ireland and advocated for personalized cardiovascular surveillance in cancer survivors.